Akebia Initiates Vadadustat Study In Covid-19 Patients
To keep development goals in sight, policymakers need to fan the embers of productivity growth
Technically Speaking: “Golden Cross” Arrives, Are The Bulls Safe?
European Update – Banks to Set the Tone
OPEC+ Meeting looms large
Google In Talks To Buy $4B Stake In India’s Jio Platform - Report
Air Canada to explore rapid COVID-19 testing
Greenback dips in EUR/USD pair
Spotify debuts new podcast top charts across 26 markets
While coronavirus cases spike in the South, the Northeast seems to have it under control - here's what changed
COVID-19 has resurrected single-use plastics – are they back to stay?
A 20,000-tonne oil spill is contaminating the Arctic – it could take decades to clean up
Biogen, Eisai Start New Phase 3 Trial For Pre-clinical Alzheimer's Disease
Tesla Climbs 6% In Pre-Market, Boosted By ‘Accelerating’ China Projects
Global Stocks Slide, Futures Flat As China Sanctions Lockheed, Virus Fears Grow
Keck Medicine of USC enrolling patients as part of international clinical trial to study antiviral drug as treatment for COVID-19
Cash Bans Coming to Your Town Next: 3 Stocks Driving The Trend
Macro Briefing | 14 July 2020
NHS Trust use of data analytics spikes amid COVID-19 crisis
Artemisinin: fighting coronavirus with this antimalarial drug is risky
German Sex Workers Demand Right To Work Amid COVID
Aldeyra Spikes 10% In Pre-Market On New Perceptive Stake
Abbott Labs, Edwards Lifesciences Settle Heart Device Patent Disputes
Mohawk Drops 5% In Extended Trading Amid Lawsuit For Improperly Boosting Sales, Margins
Pepsi Delivers Relatively Strong Q2; RBC Says One Of Top Large-Cap Ideas
Concorde 2.0? Boom Supersonic To Unveil Ultrafast Plane In October
Is China The New Indispensable Nation?
More Than Half Of COVID-19 Patients In New Study Have Heart Damage
Strong Ecosystem Will Send Alibaba Stock to an All-Time High, Says Analyst
If The US Was Japan, The Fed's Balance Sheet Would Be $25 Trillion
